The Gavi COVAX Advance Market Commitment Summit

2 June 2021 | 11:00 CEST

Watch the event recording above | View programme

World leaders unite to commit to global equitable access for COVID-19 vaccines

Global leaders and private sector companies have pledged US$ 2.4 billion to the COVAX Facility to accelerate access to 1.8 billion COVID-19 doses for lower-income economies. The pledges exceed the original US$ 2 billion target and bring the total raised to US$ 9.6 billion.

Read press release


COVAX AMC donors table

Like. Follow. Share.


    The Government of Japan will host the virtual Gavi COVAX Advance Market Commitment (AMC) Summit on 2 June 2021. The event will aim to accelerate access to 1.8 billion COVID-19 vaccine doses for lower-income economies via the Gavi COVAX Advance Market Commitment by raising an additional US$ 2 billion from donors and the private sector, in addition to US$ 6.3 billion already raised before the campaign was launched at the “One World Protected” event on 15 April 2021.

    In addition to securing resources to accelerate global vaccination coverage, the Summit will bring together world leaders, the private sector, civil society and key technical partners to reflect on the challenges, successes and lessons learned; and look ahead to potential scenarios to address the pandemic and bolster global health security for the future.


    H.E. Suga Yoshihide


    H.E. Suga Yoshihide
    Prime Minister, Japan


    José Manuel Barroso


    José Manuel Barroso
    Chair of the Gavi Board

    Gavi COVAX AMC – Investment Opportunity

    (Last updated on 15 April 2021)

    View full screen

    DOWNLOAD: English | French | SpanishChineseArabicItalian

    Japan support for Gavi

    The Japanese government has supported Gavi since 2011, making a contribution of US$ 9 million every year until 2014.

    In 2015, Japan doubled its contribution in support of health system recovery in the aftermath of the 2014 Ebola outbreaks. In May 2016. in the fringe of the G7 leaders’ Summit under its presidency, Japan for the first time announced a multi-year pledge to Gavi In 2019, Japan hosted the launch of Gavi’s third replenishment as part of TICAD 7 in Yokohama.

    At the Global Vaccine Summit in June 2020, Japan announced to commit US$ 300 million to Gavi’s 2021-2025 vaccination programmes. As one of the first countries to join COVAX, Japan has already disbursed US$ 200 million to the Gavi COVAX AMC.

    Timeline of Japanese support for Gavi

    • 2011: Japan becomes a Gavi donor at the June 2011 pledging conference, committing US$ 9.3 million in direct contributions.
    • 2015: Japan doubles its contribution in support of health system recovery after the 2014 Ebola outbreaks.
    • 2016: Under its G7 presidency, Japan announces the first multi-year pledge to support Gavi’s 2016-2020 strategic period and provided a total of US$ 94.7 million.
    • 2019: Japan hosts the launch meeting of Gavi’s third replenishment in Yokohama.
    • 2020: Commitment of US$ 300 million to Gavi's 2021-2025 vaccination programmes.
    • 2020: Japan becomes one of the first countries to join COVAX.
    • 2021: Japan co-hosts with Gavi the virtual Gavi COVAX Advance Market Commitment (AMC) Summit.

    The Gavi COVAX Advance Market Commitment (AMC) is an innovative financial mechanism that ensures the world’s poorest countries will get access to COVID-19 vaccines, regardless of their ability to pay.

    Learn more

    Latest COVAX AMC news

    21 July 2021

    From town criers to local monarchs: encouraging COVID-19 vaccination in Southern Nigeria

    Volunteers, including King Dakolo of the Epetiama kingdom, are sensitising and convincing people to accept the COVID-19 vaccine in Bayelsa State, Southern Nigeria.

    21 July 2021

    Nurses on the COVID-19 frontlines in Sierra Leone

    #VaccinesWork spoke to nurse Fatmata Kamara* about how the COVID-19 vaccine roll-out in Sierra Leone is progressing.

    20 July 2021

    The COVAX No Fault Compensation Programme: Explained

    Indemnity and liability was one of the thorniest problems COVAX had to solve to successfully roll out COVID-19 vaccines in lower-income countries. The solution is a world first, which could offer a model for future pandemics.

    5 July 2021

    Kenyans use their polio fighting network to tackle COVID-19

    A rich network of community volunteers in Nairobi are putting skills they developed during anti-polio activities to work tackling COVID-19, and mobilising slum dwellers to get the COVID-19 vaccine.

    23 June 2021

    What does COVAX’s latest supply forecast tell us?

    The forecast is encouraging given the supply disruptions COVAX and countries with bilateral deals are currently experiencing, and the general challenges manufacturers are experiencing as they ramp up supply at historic speed and scale.

    Last updated: 23 Jun 2021

    Subscribe to our newsletter